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INTRODUCTION 
After more than twenty-five years of research, the 
presence and significance of vasomotor activity in the 
pulmonary vascular bed remains a controversial subject of 
investigation. The difficulty arises in large part from the 
inability to provide an intact yet well controlled prepara¬ 
tion in which such activity can be validly demonstrated. 
Daly (1) has recently emphasized the complexity of such a 
study. Active control of the pulmonary circulation by what¬ 
ever stimulation, nervous, humoral, or gaseous, is demon¬ 
strated only under those conditions which wholly eliminate 
the participation of passive effects, namely cardiomotor, 
respiratory, bronchomotor, and bronchovascular. 
Changes in cardiac output can be controlled by perfus¬ 
ing the lungs at a constant flow rate and pressure head, but 
while this preparation is adequate to demonstrate the effect 
of gaseous and drug stimulation, neural mechanisms require 
perfusion of the bronchial vascular system as well, in order 
to maintain the vitality of the nerve tissue (2). Such a 
procedure presents additional variables of bronchial artery 
pressure and bronchial vasomotor activity, since the bron¬ 
chial vascular and pulmonary vascular systems are in com¬ 
munication (3,4). 
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Passive respiratory effects can be controlled by per- 
fusion of the isolated lung or, in the intact animal, by 
controlling lung ventilation. Even with the precaution of a 
constant volume respiratory pump, however, gases inhaled or 
drugs infused may exert passive effects by bronchomotion. 
Thus, bronchoconstrictive agents, such as acetylcholine, 
will cause an increase in pulmonary vascular resistance due 
to a direct compression effect on the small vessels of the 
lung (5). This "false", or non-vascular, rise in pulmonary 
vascular resistance may play a role in the present study. 
Neural stimulation of vasomotion has been adequately 
demonstrated in the perfused lung preparation. Stimulation 
of the thoraco-sympathetic nerves may result in intense 
vasoconstriction in the pulmonary circulation with pulmonary 
arterial pressure rises of up to 40 per cent of the resting 
value, whereas stimulation of the vagal vasodilator nerves 
has a much weaker effect (1,2). The dilator fiber effect is 
fully mimicked by acetylcholine in physiologic dosages (7)* 
The role of the autonomic nervous system in the regulation 
of the pulmonary vascular bed has been reviewed by 
Halmagyi (8). 
Although early experimenters had noted that the inha¬ 
lation of carbon dioxide increased pulmonary vascular tone, 
as evidenced by a rise in pulmonary arterial pressure, von 
Euler and Liljestrand (9) were primarily responsible for the 
interest generated in the gaseous effects on the pulmonary 
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circulation. In cats they caused a rapid rise in pulmonary 
arterial pressure by reducing the oxygen tension of the in¬ 
spired air to one-half its normal value. Conversely, they 
lowered the pulmonary arterial pressure by administering 
high concentrations of oxygen. Further, an increase in the 
carbon dioxide content of the inspired air was followed by a 
similar elevation of pulmonary arterial pressure of lesser 
magnitude. They concluded that the local pulmonary vascular 
bed was responsive to changing tensions of oxygen and carbon 
dioxide, and that the character of the response was to shunt 
blood away from underventilated or carbon dioxide contami¬ 
nated alveoli. As the rise in pulmonary arterial pressure 
was not accompanied by a rise in left atrial pressure, it 
was assumed that pulmonary vascular resistance had been in¬ 
creased by hypoxia. Measuring the pulmonary arterial 
pressure, left atrial pressure, and cardiac output, Stroud 
and Rahn (10) subjected animals to stepwise reductions in 
the oxygen percentage of inspired air, and found resistance 
to increase in a graded fashion with increasing degrees of 
hypoxia. These findings have been shown to be true in man 
as well by Westcott el al (13) and other investigators (11, 
12,14,15). The converse, that an enrichment of the oxygen 
content of alveolar air causes a reduction of pulmonary 
vascular resistance is somewhat less clear. Westcott et al 
(13) found no change in normal subjects ventilated with 
100 per cent oxygen, but showed a significant decrease in 
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pulmonary arterial pressure in patients with pulmonary 
hypertension under the same conditions. More recently, 
similar findings have been reported in patients with mitral 
stenosis (16), congenital heart disease with pulmonary 
hypertension (17,18,19), and idiopathic pulmonary hyper¬ 
tension (20,21), although Marshall et al (22) found there to 
be no essential difference in the pulmonary vascular re¬ 
sistance under conditions of room air and 100 per cent oxy¬ 
gen ventilation in this latter group. 
While the mechanism is not entirely clear, it is well 
established that hypoxic states are accompanied by vaso¬ 
constriction in the pulmonary bed, most pronounced when the 
resting pulmonary arterial pressure is elevated, and that 
hyperoxic states are accompaned by vasodilatation of lesser 
degree. The significance of these changes in the normal 
pulmonary circulation is undetermined. In an excellent 
review of the problem, Fishman (23) concludes that passive 
cardiorespiratory influences predominate over vasomotion in 
the regulation of the normal pulmonary circulation, and that 
respiratory gases act only as a fine adjustment of this 
circulation. 
In general, drugs Injected directly into the lesser 
circulation will act first on the pulmonary vascular bed, 
then on the more peripheral portions of the airway, and 
finally, by recirculation on the drug, on the bronchial and 
systemic circulations. The systemic pharmacologic effects 
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of acetylcholine are well known, and only a few points 
pertinent to the present study deserve reiteration here. In 
animals acetylcholine produces a generalized vasodilatation, 
especially of the smaller blood vessels, and a consequent 
fall in blood pressure. There is most often a bradycardia. 
The evanescent character of the response is due to two 
mechanisms: firstly, the rapid hydrolytic destruction of the 
ester by serum cholinesterase, and secondly, the opposition 
of the nicotinic effects of the drug, that is, the rise in 
arterial blood pressure and the cardioacceleration due to 
sympathoadrenal discharge mediated by the drug. 
In man nearly all these effects are diminished, and 
although some vasodilatation occurs in the normal indi¬ 
vidual, the fall in blood pressure is minimal because of the 
rapid destruction mentioned above and the efficient com¬ 
pensatory cardiovascular reflexes mediated through the ca¬ 
rotid pressoreceptors (24). The adrenal response may also 
play a role. Only in large doses (20-60 mg/min) are the 
systemic effects similar to those observed in animals. The 
bradycardia does not occur; in fact, cardioacceleration is 
more common. Systolic and diastolic blood pressure are not 
lowered appreciably, and there is no significant alteration 
in cardiac output. 
in animals effective doses of acetylcholine may cause 
bronchospasm and hyperpnea is common, whereas in man there 
may be transient inspiratory difficulty, but in general the 
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respiratory effects are minimal even after large doses. 
Thes species differences in the circulatory and re¬ 
spiratory response to acetylcholine may well account in part 
for the difficulty experienced in obtaining consistent re¬ 
sults in animal experimentation. The relative insensitivity 
of the human systemic circulation and respiration to the 
effects of the drug may, with the aid of direct pulmonary 
artery infusion, so mitigate the systemic and passive re¬ 
spiratory effects as to allow for a clear demonstration of 
the pulmonary circulatory effect. 
In general, animal experimentation with the drug has 
been disappointing, as both pulmonary vasoconstriction and 
vasodilatation have been reported (2,5,25,26). However, a 
certain trend was apparent in the early work with the drug 
in that low dosages were usually associated with pulmonary 
vasodilatation, evidenced by a fall in pulmonary arterial 
pressure, and higher dosages with vasoconstriction and a 
rise in pressure (7). Recently, Borst et al (27) infused 
acetylcholine into the pulmonary artery of one lung and, 
measuring the redistribution of blood flow as evidence of 
vasoactivity, demonstrated vasoconstriction in two dogs, 
vasodilatation in two, no change in one, and a diphasic re¬ 
sponse in another. Similarly Niden et al (28) found the 
response of the pulmonary arterial pressure following 
acetylcholine infusion to be inconsistent in the normal dog. 
We are indebted to Harris (29) for the technique 
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presently used in assessing the effect of acetylcholine on 
the pulmonary circulation in man. Recognizing the fact that 
acetylcholine is rapidly destroyed in the bloodstream (6) 
and using the standard technique of right heart catheteriza¬ 
tion, Harris was able to infuse acetylcholine directly into 
the pulmonary artery in amounts small enough to insure its 
destruction before reaching the systemic circulation. The 
procedure required, however, accounts for the limited number 
of studies on the normal pulmonary circulation. 
Fritts et al (11) were able to demonstrate a small but 
consistent fall in the pulmonary arterial pressure following 
acetylcholine infusion into 13 normal subjects, but the most 
productive studies have been those conducted in patients 
with a variety of cardiac and pulmonary diseases, whose 
common factor was an elevated resting pulmonary arterial 
pressure. Harris (30) was able to produce a fall in pulmon¬ 
ary arterial pressure in 18 of 47 patients, and noted that 
the magnitude of the response was directly related to the 
elevation of the resting pressure over a wide range, 
although patients with severe pulmonary hypertension were 
less responsive. He postulated that the vasodilatation pro¬ 
duced by acetylcholine represented the release of a protec¬ 
tive active vasoconstriction in the pulmonary vascular bed 
of these patients associated with medial muscular hyper¬ 
trophy; and that with time and severity, fibrosis and per¬ 
manent anatomical change was superimposed on this process, 
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making the vessels unresponsive to acetylcholine release. 
Wood et al (31) found a consistent decrease in pulmonary 
arterial pressure and calculated pulmonary vascular resist¬ 
ance following acetylcholine in patients with mitral 
stenosis and primary pulmonary hypertension. Wood (32) 
further suggested that the vasoconstriction in these 
patients may be secondary to the elevated pulmonary arterial 
pressure initially, but leads to further increases in the 
pressure, thus completing a vicious circle and resulting 
eventually in obliterative pulmonary hypertension. 
Soderholm and Werko (33) and others (34,35,36,37,38,39) have 
confirmed these findings in cases of mitral valvular disease. 
Similar changes in pulmonary arterial pressure and pulmonary 
vascular resistance have followed acetylcholine infusion in 
congenital heart disease with hypertension (18,19), primary 
pulmonary hypertension (21,22,32,43), and primary lung dis¬ 
eases (40,41,42). Left atrial pressure, heart rate, and 
cardiac output were measured in the majority of the above 
studies and found to be unchanged or insignificantly 
altered. Oakley et al (15) reported a decrease in pulmonary 
distending pressure and an increase in pulmonary blood vol¬ 
ume with acetylcholine infusion, and concluded from these 
that active vasodilatation had been effected by the drug in 
patients with mitral disease. 
The above studies clearly define the role of vasomotor 
tone in maintaining the pulmonary arterial pressure and pul- 
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monary vascular resistance in the disease states studied. 
However, the evidence for vasodilatation following acetyl¬ 
choline in the normal man and dog is less convincing, and 
vasomotor activity appears to be of little physiologic 
significance in the normal pulmonary circulation. 
Most recently, investigations have centered around the 
effect of acetylcholine on gas exchange in the lung, particu¬ 
larly the systemic arterial oxygen saturation (SaOg). There 
was no significant change in SaOg accompanying the small 
pulmonary arterial pressure fall in normal human subjects, 
but when the vascular bed had been constricted by respiring 
a hypoxic mixture, acetylcholine produced a significant fall 
in Sa02 (11). Soderholm and Werko (33) demonstrated a mean 
SaC>2 decrease of 7 per* cent following acetylcholine in 
patients with mitral valvular disease, and these results 
have been confirmed by others (16,34,37,38), although this 
was not apparent in a study by Bishop et al (35). Similar 
findings have been reported in congenital heart disease (19) 
and pulmonary disease (40,41,42). 
The mechanism of acetylcholine induced desaturation is 
unclear. The fact that it appears when the systemic effects 
of bronchoconstriction have been eliminated and in the pres¬ 
ence of a normal or decreased arterial carbon dioxide 
tension makes it unlikely that there is alveolar hypo¬ 
ventilation secondary to a generalized bronchoconstrictor 
effect of the drug. Arteriovenous anastomoses have been 
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repeatedly demonstrated in the lung by Prinzmetal et al (44) 
and others (45,46,47,48,49), and the possibility exists that 
these are selectively dilated by acetylcholine, allowing 
venous blood to bypass the alveoli. Using the microsphere 
technique, Ring et al (51) has submitted evidence in favor 
of vasodilatation of these shunts with acetylcholine, 
although Rondell et al (50) had previously reported no 
effect with the drug. Stanfield et al (34) reported a lower¬ 
ing of the systemic arterial oxygen saturation and arterial 
oxygen tension (p02) with acetylcholine infusion in patients 
with mitral stenosis, but were able to eliminate both effects 
by allowing the patients to breathe 100 per cent oxygen. On 
this basis they concluded that no significant arteriovenous 
shunting had taken place and that the most probable mechan¬ 
ism of the desaturation was an alteration in the ventila¬ 
tion/perfusion ratio of the lung. If in certain areas of 
the lung alveolar hypoventilation exists, it will be attended 
by vasoconstriction due to the hypoxic stimulus, and there¬ 
fore a low perfusion. The net result is a compensated non- 
uniform ventilation/perfusion ratio and normal arterial 
oxygen saturation and tension levels (52). With acetyl¬ 
choline infusion vasodilatation occurs and the non-uniform 
ventilation/perfusion ratio is revealed, with a consequent 
fall in Sa02 and pC>2* 
Infusing acetylcholine into the pulmonary circulation 
of intact and perfused dog preparations, Niden et al (28) 
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were able to demonstrate a consistent fall in SaCg (average 
fall = 1.3 per cent) with the animals breathing room air. 
However, increasing the oxygen content of the inspired air 
to 30 per cent resulted in a diminution of the response, and 
with 100 per cent oxygen the effect was totally abolished. 
They concluded that while local ventilation/perfusion 
changes might well be responsible for the desaturation 
effect, true anatomical shunting could not be ruled out on 
the basis of the absence of the effect in the presence of 
100 per cent oxygen. The degree of desaturation noted while 
breathing air was such that an anatomical shunt, if present, 
might have been masked by the administration of 100 per cent 
oxygen. This might result from the amount of oxygen dis- 
solved in the plasma at this high arterial blood tension. 
Therefore, an anatomical shunt is not excluded by the elimi¬ 
nation of the response with 100 per cent oxygen. In 
addition, the oximeter method used offers only limited 
accuracy in assessing small changes in oxygen saturation. 
In view of the above, the present study was designed 
to avoid the relative insensitivity of the oxygen dissocia¬ 
tion curve to changes at high oxygen levels by direct 
arterial oxygen tension measurements. In this way it was 
proposed to study the effect of acetylcholine infusion on 
the arterial oxygen tension under conditions of room air and 
100 per cent oxygen ventilation. 
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MATERIALS AND METHODS 
Seven mongrel dogs varying in weight from 6.4 to 
15.4- kg were anesthetized with i.v. pentobarbital sodium 
(30 mg/kg). The trachea was cannulated and respiration 
controlled by means of a constant volume respiration pump 
(Model 667, Harvard Apparatus Co.) at a stroke volume of 
150-300 cc and a rate of 16-22 strokes/min depending on the 
size and weight of the animal. A cylinder containing 100 
per cent oxygen was attached to the pump via a balloon for 
those trials requiring ventilation with 100 per cent oxygen. 
In these cases the animal was allowed to inspire oxygen for 
at least five minutes before drug infusions were begun. 
The electrocardiogram was monitored from Lead II 
throughout the experiments. 
A Cournand catheter (No.6) was passed into the main 
pulmonary artery via the right external jugular vein and 
right heart, and was connected to a Statham pressure trans¬ 
ducer (Model P23D) for the continuous measurement of 
pulmonary arterial pressure. This was recorded on a Gilson 
M8P recorder. 
A second Cournand catheter (No.6) for the purpose of 
drug infusion was passed into the main pulmonary artery via 
the right femoral vein and situated just distal to the 
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pulmonic valve to insure the maximum drug effect on both 
lungs. The positions of the catheters were verified by 
pressure tracings and by fluoroscopy. Patency of the 
catheters was insured by intermittent flushing with 5% 
dextrose in water solution, to which 5mg/l heparin had been 
added. The infusion catheter was connected to a constant 
infusion/withdrawal pump (Model 600-900, Harvard Apparatus 
Co.), which provided for alteration in amount of drug and 
rate infused. 
The right femoral artery was cannulated with poly- 
ethylene tubing (Intramedic, PE-240/S12) and connected via 
a second Statham pressure transducer to the Gilson recorder 
for continuous measurement of systemic arterial pressure. 
The animal was anticoagulated with heparin solution 
(3 mg/kg). 
Arterial oxygen tension was measured directly by means 
of a Severinghaus oxygen tension electrode and a Beckman 
Physiological Gas Analyzer (Model 160). The zero setting 
was established by flushing the electrode with nitrogen 
gas and the sensitivity span set to 150 mmHg with room air. 
The temperature of the electrode was maintained at 37°C by 
means of a water bath apparatus. Under these conditions 
the accuracy of the electrode was within 1 mmHg at room air 
and within 10 mmHg with 100 per cent oxygen. 
The left femoral artery and vein were cannulated with 
polyethylene tubing (as above) and connected so as to 
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provide a continuous flow of arterial blood past the 
electrode (fig.1). The rapidity of the response varied 
according to the membrane used but generally approximated 
five seconds. 
Acetylcholine was freshly prepared and diluted just 
before use. Infusions were begun only after a suitable 
period of stabilized arterial oxygen tension recordings. 
Dosages varied from 0.005 to 2.0 mg/min and the amount in¬ 
fused never exceeded 5 cc. Infusions were continued until 
stable values were obtained for arterial oxygen tension, 
pulmonary arterial pressure, and systemic arterial pressure. 
This was usually apparent after two minutes of infusion. 
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RESULTS 
The results of the study appear in Tables I-IV. For 
the purpose of analysis, the infusion trials were divided 
into two groups according to the dosage of acetylcholine 
administered. 
Group A included infusion rates of 1.0 to 2.0 mg/min 
and was comprised of eight trials, six of them carried out in 
Dogs 1 and 2, and one each in Dogs 3 and 5. Infusions here 
were invariably accompanied by systemic hypotension of sig¬ 
nificant degree (average systolic pressure fall = 84 mmHg; 
average diastolic fall = 63 mmHg). A significant bradycardia 
(average rate decrease = 28/min) was present in four trials, 
a slight tachycardia in three, and a marked tachycardia in 
one. Pulmonary arterial pressure changes were inconsistent 
in direction and generally of low magnitude (1-2 mmHg). The 
pulmonary arterial pressure rose in five trials, fell in one, 
and showed no essential change in two. 
Respiring the animals with 100 per cent oxygen resulted 
in no apparent alteration of the acetylcholine effect when 
these trials were compared with those at room air in the 
individual dog or in the group. During the four trials with 
the animals breathing room air, the arterial oxygen tension 
fell consistently, although the magnitude of the fall varied 
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considerably (1-25 mmHg). Following ventilation with 100 per 
cent oxygen, however, the response was inconsistent and less 
significant. 
Group B included a total of 21 infusion trials, nine of 
which were carried out with 100 per cent oxygen ventilation. 
The experiments involved Dogs 3,4,5,6, and 7. The dosage of 
acetylcholine infused varied from 0.005 to 0.5 mg/min. 
Systemic hypotension was similarly present in all trials, but 
was of lesser magnitude than in Group A (average systolic 
pressure fall = 20 mmHg; average diastolic fall = 19 mmHg). 
Acetylcholine infusion was accompanied by an increase in the 
heart rate in 15 of the 21 trials, by a slowing in three, 
and by no change in one. The pulmonary arterial pressure 
response showed some degree of specificity in the individual 
animals. Dog 3 responded to the infusions with an increase 
in pulmonary arterial pressure in all trials, and with a 
further increase (8 mmHg) upon ventilation with 100 per cent 
oxygen. Dogs 4,5,6, and 7 showed both elevation and depres¬ 
sion of the pulmonary arterial pressure. These changes bore 
no apparent relationship in direction or degree to the 
oxygen content of the inspired gas. 
The arterial oxygen tension effects were slight and 
inconsistent. While respiring room air, Dog 3 showed both a 
rise and a fall in p02. In the case of Dog 4, the lowering 
of arterial pC>2 was more prominent; in Dog 5 there was either 
a lowering or no change. However the pC>2 rose in Dog 6, and 
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both a rise and a fall were present in Dog 7. With 100 per 
cent oxygen ventilation, two animals (3 and 4) showed an 
elevation of arterial PO2; three (5,6, and 7) responded with 
a fall in p02. 
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TABLE I 
FiC>2 = Fraction of oxygen in the inspired air 
SAP = Systemic arterial pressure 
PAP = Pulmonary arterial pressure 
S = Systolic 
D = Diastolic 
pC>2 = systemic arterial oxygen tension 
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TABLE II 
Summary of changes in Group A 
Dog 
Rate 
mg/min fio2 
SAP 
S D 
PAP 
S D 
p02 
mmHg 
Heart 
rate 
1 2.0 1 .00 -115 - -70 +2 + 1 0 +8 
2.0 .21 
-95 -80 +2 0 inc +4 
2.0 .21 -80 -45 -7 -2 -25 -40 
2.0 1 .00 -30 -15 -1 + 1 -20 -16 
2 2.0 .21 -138 - 100 -1 +4 -1 -36 
2.0 1 .00 -90 -82 + 17 +2 +10 +64 
3 1 .0 .21 -60 -50 +4 0 -14 -20 
4 1 .0 .21 -68 -52 + 1 + 1 -4 +8 
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TABLE III 
Effect of acetylcholine infusion in Group B 
Rate 
Dog mg/min Fi02 
SAP 
S D S 
PAP 
D 
P0o 
mmRg 
Heart 
rate 
3 0.5 .21 103 80 10 6 78 168 
87 62 11 6 - 168 
(12.5 kg) 
0.5 1 .00 115 87 8 5 500 176 
95 60 16 7 510 180 
0.5 .21 130 102 9 4 61 184 
110 72 13 6 65 180 
4 0.1 .21 62 32 15 6 85 78 
40 20 12 6 86 76 
(9.4 kg) 
0.1 1 .00 60 35 15 8 380 82 
35 18 14 7 - 88 
0.1 1 .00 78 55 9 6 335 94 ! 
52 27 10 7 395 100 
0.1 .21 100 73 7 4 90 110 
70 30 9 5 85 84 
0.05 .21 96 73 6 4 79 100 
95 70 6 4 75 104 
5 0.5 .21 60 32 18 8 88 114 
57 30 20 10 84 118 
(6.4 kg) 
0.5 .21 90 60 21 10 87 118 
49 25 25 13 87 1 34 
0.5 1 .00 110 80 25 11 565 126 
85 50 27 13 560 144 
0.5 1 .00 122 85 27 11 565 132 
100 57 30 14 565 156 
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TABLE III (cont.) 
Rate 
Dog mg/min Fi02 
SAP 
S D 
PAP 
S D 
p02 
mmfig 
Heart 
rate 
0.5 1 .00 130 88 28 12 575 132 
70 40 28 12 565 140 
0.25 1 .00 117 82 27 1 1 565 120 
92 56 25 11 560 130 
0.25 .21 78 42 28 12 94 128 
70 40 23 12 94 124 
0.25 .21 90 57 24 1 1 93 128 
80 49 23 12 91 128 
6 0.01 .21 185 130 26 12 146 196 
180 135 28 15 152 196 
(13.2 kg) 
0.005 1 .00 200 145 26 13 675 176 
190 135 24 12 665 188 
0.01 .21 215 145 26 12 77 136 
190 140 27 12 81 176 
7 0.01 .21 145 95 17 8 88 224 
130 80 14 8 91 248 
(15.4 kg) 
0 o 25 1 .00 132 87 15 4 620 220 
112 82 16 4 600 244 
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TABLE IV 
Summary of changes in Group B 
Dog 
Rate 
mg/min Fi02 
SAP 
S D 
PAP 
S D 
P°2 
mmHg 
Heart 
rate 
3 0.5 .21 -16 -18 + 1 0 inc 0 
0.5 1 .00 -20 -27 +8 +2 + 10 +4 
0.5 .21 -20 -30 +4 +2 +4 -4 
4 0.1 .21 -22 -12 _■* 0 +1 -2 
0.1 1 .00 
-25 -17 -1 -1 inc +6 1 
0.1 1 ,00 -26 -28 + 1 + 1 +60 +6 
0.1 .21 -30 -43 +2 + 1 -5 -26 
0.05 .21 -1 0 0 -4 +4 
5 0.5 .21 -3 -2 +2 +2 -4 +4 
0.5 .21 -41 -35 +4 +3 0 + 16 
0.5 1 .00 -25 -30 +2 +2 + 18 
0.5 1 .00 -22 -28 +3 +3 0 + 14 
0.5 1 .00 -60 -48 0 0 -10 +8 
0.25 1 .00 -25 -22 -2 0 + 10 
0.25 .21 -8 -2 -1 0 0 +4 
0.25 .21 -10 -8 -1 +1 -2 0 
6 0.01 . .21 _R +5 +2 +3 +6 0 
0.005 1 .00 -10 -10 -2 -1 -10 + 12 
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TABLE IV (cont.) 
Dog 
Rate 
rag/min fio2 
SAP 
S D 
PAP 
S D 
p02 
mmHg 
Heart 
rate 
0.01 .21 
-25 -5 + 1 0 +4 +40 
7 0.01 • 21 -15 -15 -3 0 -20 +24 
0.25 1 .00 
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-15 + 1 0 -20 +24 
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DISCUSSION 
Systemic Arterial Pressure 
The rapid.and severe systemic hypotension which invaria¬ 
bly followed infusion of larger doses of acetylcholine 
(Group A) is characteristic of and attributable to systemic 
vasodilatation as a direct effect of the drug (24). In all 
cases the pressure resumed its normal level when the infusion 
had been discontinued. Following smaller dosages of acetyl¬ 
choline (Group B) this effect was still present, though less 
marked. 
Heart Rate 
The bradycardia following acetylcholine infusion in 
Group A is also attributable to a direct effect on the heart 
(the "vagal effect"). With smaller doses of the drug 
(Group B), however, the predominant response was cardio- 
acceleration, which most likely represents reflex inhibition 
of vagal tone mediated via the aortic and carotid baro- 
receptors in response to the systemic hypotension. In the 
absence of sufficient drug to produce the slowing of the 
heart rate seen in Group A, this latter effect predominates, 
with the consequent tachycardia. 
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Pulmonary Arterial Pressure 
In general, acetylcholine infusion in Group A was 
attended by a rise in pulmonary arterial pressure. Assuming 
that the decrease in systemic pressure and heart rate 
already mentioned are evidence of a generalized acetyl¬ 
choline effect on the systemic circulation in this group, 
it is most probable that the characteristic respiratory 
effect, namely generalized bronchoconstriction, was also 
present. While the respiratory volume was maintained by a 
constant volume respiration pump, the intratracheal pressure 
was not measured and cannot be assumed to have remained 
constant. Bronchoconstriction might easily have accounted 
for the rise in pulmonary arterial pressure in this group in 
a passive manner, making it unnecessary to invoke a primary 
drug effect on the pulmonary circulation. 
With smaller doses of acetylcholine (Group B) the 
pulmonary arterial pressure response was less consistent, 
with both increases and decreases being observed. As the 
effects of acetylcholine are dose related, bronchoconstric¬ 
tion, while present, plays a lesser role in this group. In 
addition, significant alterations in systemic pressure and 
heart rate can be expected to reduce cardiac output and 
cause a passive lowering of pulmonary arterial pressure in 
this way. In most trials the changes observed represent the 
net effect of these passive forces. When only those trials 
were considered, wherein changes in systemic pressure and 
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heart rate were insignificant, the pulmonary arterial 
pressure response was minute and inconsistent. These 
findings are in agreement with those of Borst et al (2?) and 
Niden et al (28). 
It is interesting that in four animals (Dogs 1,2,3, and 
7) pulmonary arterial pressure fell upon ventilation with 
100 per cent oxygen. In the absence of systemic effect, 
this may represent pulmonary vasodilatation similar to that 
observed by von Euler and Liljestrand in the cat (9). 
Arterial Oxygen Tension 
Changes in arterial oxygen tension may ordinarily 
result from any of the following: (a) changes in ventilation 
(volume or distribution), (b) changes in diffusion of oxygen 
from the alveolus to the blood, (c) changes in perfusion, 
overall or local, (d) opening or closing of arteriovenous 
anastomoses, or (e) artefacts in measurement. 
The results of acetylcholine infusion in Group A show 
a consistent fall in arterial oxygen tension, but in view 
of the systemic drug effects in this group this finding is 
less significant. Generalized hypoventilation secondary to 
the bronchoconstriction already mentioned is probably the 
central factor in lowering the arterial oxygen tension in 
this series. With 100 per cent oxygen ventilation, arterial 
oxygen tension changes are minimal and inconsistent, which 
lends support to the role of this factor. 
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Arterial oxygen tension changes in Group B were of 
small magnitude and varied direction. As the systemic 
effects were less marked in this group, it is unlikely that 
changes in overall ventilation and perfusion contributed 
appreciably to these changes. While either local changes in 
ventilation/perfusion ratio or true anatomical shunting may 
be present, the inconsistency of the response makes these 
factors difficult to evaluate. In addition, artefacts of 
measurement due to delayed electrode response, stagnation 
of the shunted blood in the area of the electrode, and the 
normal margin of error of the electrode may well account for 
changes of this magnitude. Therefore, it may be concluded 
that within the limits of the above preparation, no signifi¬ 
cant alteration in the arterial oxygen tension could be 
demonstrated following acetylcholine infusion. 
In the demonstration and assessment of acetylcholine 
induced vasodilatation the experimental approach is limited 
by (a) the participation of passive effects, as discussed 
earlier, and (b) the small magnitude of the response in the 
normal pulmonary vasculature. While it is theoretically 
possible to increase the sensitivity of the recording 
apparatus, one might better attack the latter problem by 
enhancing the pulmonary vascular response to the drug in¬ 
fused. Recognizing that the magnitude of the dilatation 
response is directly related to the resting tone of the 
vessels, Rudolph et al (53) increased the resting tone of 
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the pulmonary vasculature in dogs by infusing serotonin 
prior to acetylcholine trials. In this way they were able 
to demonstrate a consistent fall in the pulmonary arterial 
pressure following acetylcholine in the serotonin-constricted 
pulmonary vessels. While the use of a second drug imposes 
additional variables on the experimental system, this 
technique seems worthy of trial in studies designed to 
elucidate the effect of acetylcholine on the arterial oxygen 
tension 
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SUMMARY 
Acetylcholine in varying dosages was infused directly 
into the pulmonary artery of seven dogs, under conditions 
of room air and 100 per cent oxygen ventilation, and the 
changes in arterial oxygen tension recorded. 
With larger dosages of the drug, effects on the 
pulmonary vasculature and changes in arterial oxygen tension 
were masked or obliterated by the predominating systemic 
effect of the drug. 
With smaller dosages, changes in the arterial oxygen 
tension were apparent but were generally of small magnitude 
and inconsistent direction. 
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